Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alloimmunization following blood transfusion.

R H Walker1, D T Lin, M B Hartrick

  • 1William Beaumont Hospital, Royal Oak, MI 48072.

Archives of Pathology & Laboratory Medicine
|March 1, 1989
PubMed
Summary

Despite the widespread use of Rh immunoglobulin (Rhlg), anti-D alloantibodies persist in hospital patients. Alloimmunization from transfusions remains a clinical concern, necessitating ongoing vigilance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

McLeod syndrome: Five new pedigrees with novel mutations.

Parkinsonism & related disorders·2019
Same author

Hippocampal sclerosis and mesial temporal lobe epilepsy in chorea-acanthocytosis: a case with clinical, pathologic and genetic evaluation.

Neuropathology and applied neurobiology·2017
Same author

Rapid disease progression in adult-onset mitochondrial membrane protein-associated neurodegeneration.

Clinical genetics·2013
Same author

Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes.

Translational psychiatry·2012
Same author

Constipation.

McGill medical journal·2010
Same author

Profile measurements of cylindrical surfaces.

Applied optics·2010

Area of Science:

  • Transfusion Medicine
  • Immunology
  • Hematology

Background:

  • Anti-D alloantibodies remain a significant clinical concern in hospital patients, despite two decades of Rh immunoglobulin (Rhlg) use.
  • Anti-D is the second most frequent clinically significant alloantibody, following anti-K.

Purpose of the Study:

  • To analyze trends in alloantibody frequencies in hospital patients.
  • To investigate factors contributing to the persistence of anti-D and the rise of other alloantibodies.

Main Methods:

  • Review of alloantibody frequencies in hospital patient populations.
  • Analysis of red cell use factors and transfusion practices.
  • Examination of alloimmunization risks from homologous blood components.

Main Results:

  • A gradual decline in anti-D and anti-CD frequencies was observed.
  • Increases in the relative and absolute frequencies of anti-K, anti-E, and anti-Jka were noted.
  • Potential correlation between optimal Rhlg use, aggressive transfusion strategies, and increasing patient illness severity.

Conclusions:

  • Optimal Rh immunoglobulin (Rhlg) use and evolving transfusion practices may influence alloantibody profiles.
  • Increasing patient acuity might contribute to observed trends in alloantibody frequencies.
  • Alloimmunization from white blood cells, platelets, and proteins in transfused blood presents ongoing risks.

Related Experiment Videos